Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Cellular distribution of a disintegrin and metalloproteinases (ADAM)-9 expression in hepatocellular carcinoma (HCC) and non-tumorous liver tissues.

Published byPhilippa Booker Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1. Cellular distribution of a disintegrin and metalloproteinases (ADAM)-9 expression in hepatocellular carcinoma (HCC) and non-tumorous liver tissues."— Presentation transcript:

1 Figure 1. Cellular distribution of a disintegrin and metalloproteinases (ADAM)-9 expression in hepatocellular carcinoma (HCC) and non-tumorous liver tissues (original magnification ×400). (A) ADAM-9-negative staining was seen in non-tumorous liver tissues. (B) ADAM-9-positive staining was indicated by numerous yellowish granules in the cytoplasmic and membrane cellular compartment of tumor cells. (C) Representative ADAM-9-negative case of HC; normal bile duct cells indicate positive immunostaining for ADAM-9, as an internal positive control. (BD, bile duct). From: Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis Jpn J Clin Oncol. 2010;40(7): doi: /jjco/hyq030 Jpn J Clin Oncol | © The Author (2010). Published by Oxford University Press. All rights reserved 1

Download ppt "Figure 1. Cellular distribution of a disintegrin and metalloproteinases (ADAM)-9 expression in hepatocellular carcinoma (HCC) and non-tumorous liver tissues."

Similar presentations

Figure 3. Persistent DNA damage in normal-looking part of the livers of the Sgo1−/+ mice. (A) The DNA damage marker phospho-gamma-H2AX and p53.

Figure 3. Persistent DNA damage in normal-looking part of the livers of the Sgo1−/+ mice. (A) The DNA damage marker phospho-gamma-H2AX and p53.
Case Rep Gastroenterol 2015;9: DOI: /

Case Rep Gastroenterol 2015;9: DOI: /
Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.

Figure 1. Scree plot for the exploratory factor analysis (EFA) of the Death Depression Scale (DDS). From: Development and psychometric evaluation of a.
Podocalyxin-Like Protein 1 Expression and Correlation with Clinical Characteristics in Epithelial Serous and Mucinous Ovarian Carcinoma and Tumor-Like.

Podocalyxin-Like Protein 1 Expression and Correlation with Clinical Characteristics in Epithelial Serous and Mucinous Ovarian Carcinoma and Tumor-Like.
  TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson

  TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson
Volume 144, Issue 1, Pages 7-14 (May 1999)

Volume 144, Issue 1, Pages 7-14 (May 1999)
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast  Charles C. Wykoff, Nigel Beasley,

Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast  Charles C. Wykoff, Nigel Beasley,
Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma  Hideyuki Imoto, MD, Toshihiro.
Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.

Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.
Figure 1 (A) Chest computed tomography scans of the patient

Figure 1 (A) Chest computed tomography scans of the patient
Figure 2. Kaplan–Meier survival analysis in patients

Figure 2. Kaplan–Meier survival analysis in patients
Copyright © 2015 by the American Osteopathic Association.

Copyright © 2015 by the American Osteopathic Association.
Fig. 1. Immunostaining for AhR in non-neoplastic urothelium ( A ), superficial UC ( B ) and invasive UC ( C ). ( A ) Weak cytoplasmic staining in the.

Fig. 1. Immunostaining for AhR in non-neoplastic urothelium ( A ), superficial UC ( B ) and invasive UC ( C ). ( A ) Weak cytoplasmic staining in the.
Figure S2 a b DBH-AS1 hDREH HBV-HCC HCV-HCC HDV-HCC HBV-HCC HCV-HCC

Figure S2 a b DBH-AS1 hDREH HBV-HCC HCV-HCC HDV-HCC HBV-HCC HCV-HCC
Human Urinary Bladder Transitional Cell Carcinomas Acquire the Functional Fas Ligand during Tumor Progression  Dominique Chopin, Reza Barei-Moniri, Pascale.

Human Urinary Bladder Transitional Cell Carcinomas Acquire the Functional Fas Ligand during Tumor Progression  Dominique Chopin, Reza Barei-Moniri, Pascale.
Case Rep Gastroenterol 2013;7: DOI: /

Case Rep Gastroenterol 2013;7: DOI: /
Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.

Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.
Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.
Figure 1. The (a) anterior–posterior and (b) right-lateral fields and (c, d) the isodose distributions of two axial planes in one patient with T2 stage.

Figure 1. The (a) anterior–posterior and (b) right-lateral fields and (c, d) the isodose distributions of two axial planes in one patient with T2 stage.
Chapter 14 Hepatic Tumors, Malignant 1

Chapter 14 Hepatic Tumors, Malignant 1

Similar presentations

Ads by Google